ZA856277B - 2,3-dihydrobenzofuran-5-sulfonamide derivatives - Google Patents
2,3-dihydrobenzofuran-5-sulfonamide derivativesInfo
- Publication number
- ZA856277B ZA856277B ZA856277A ZA856277A ZA856277B ZA 856277 B ZA856277 B ZA 856277B ZA 856277 A ZA856277 A ZA 856277A ZA 856277 A ZA856277 A ZA 856277A ZA 856277 B ZA856277 B ZA 856277B
- Authority
- ZA
- South Africa
- Prior art keywords
- dihydrobenzofuran
- sulfonamide derivatives
- parenterally
- classified
- effects
- Prior art date
Links
- YSWWLKULIVOPEP-UHFFFAOYSA-N 2,3-dihydro-1-benzofuran-5-sulfonimidic acid Chemical class NS(=O)(=O)C1=CC=C2OCCC2=C1 YSWWLKULIVOPEP-UHFFFAOYSA-N 0.000 title abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 229940124567 diuretic antihypertensive agent Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000002171 loop diuretic Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59186971A JPS6163671A (ja) | 1984-09-05 | 1984-09-05 | ２，３−ジヒドロベンゾフラン−５−スルホンアミド誘導体および降圧利尿剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA856277B true ZA856277B (en) | 1986-04-30 |
Family
ID=16197928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA856277A ZA856277B (en) | 1984-09-05 | 1985-08-19 | 2,3-dihydrobenzofuran-5-sulfonamide derivatives |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4659709A (xx) |
| EP (1) | EP0173899B1 (xx) |
| JP (1) | JPS6163671A (xx) |
| KR (1) | KR930002100B1 (xx) |
| AT (1) | ATE70534T1 (xx) |
| AU (1) | AU592060B2 (xx) |
| CA (1) | CA1265800A (xx) |
| DE (1) | DE3584919D1 (xx) |
| DK (1) | DK165954C (xx) |
| GB (1) | GB2164039B (xx) |
| IE (1) | IE58911B1 (xx) |
| NO (1) | NO169487C (xx) |
| NZ (1) | NZ213197A (xx) |
| PT (1) | PT81033B (xx) |
| ZA (1) | ZA856277B (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5116874A (en) * | 1985-09-23 | 1992-05-26 | Eli Lilly And Company | Anti-tumor method and compounds |
| JPH01100164A (ja) * | 1987-10-12 | 1989-04-18 | Shionogi & Co Ltd | スルファモイル−２−ベンゾフランカルボン酸誘導体 |
| EP0322692B1 (de) * | 1987-12-24 | 1991-03-06 | Roche Diagnostics GmbH | Heterocyclisch substituierte Alkylsulfonamide, Verfahren zu ihrer Herstellung sowie Arzneimittel |
| GB9110636D0 (en) * | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Chemical compounds |
| US5254582A (en) * | 1992-02-05 | 1993-10-19 | Eli Lilly And Company | Antitumor compositions and methods |
| US5387681A (en) * | 1992-08-19 | 1995-02-07 | Eli Lilly And Company | Synthesis of bicyclic aromatic sulfonic acids sulfonyl chlorides and sulfonamides |
| US6150402A (en) * | 1994-08-15 | 2000-11-21 | Loma Linda University Medical Center | Natriuretic compounds |
| DE10135499A1 (de) * | 2001-07-20 | 2003-01-30 | Merck Patent Gmbh | Indanverbindungen mit negativem Delta-epsilon |
| WO2005037223A2 (en) * | 2003-10-15 | 2005-04-28 | Brigham And Women's Hospital, Inc. | Methods and compositions for immunomodulation |
| AU2005307006B2 (en) | 2004-10-29 | 2012-05-03 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| ES2691548T3 (es) * | 2005-10-25 | 2018-11-27 | Kalypsys, Inc. | Sales de moduladores de PPAR y métodos para tratar desórdenes metabólicos |
| US20080176861A1 (en) | 2007-01-23 | 2008-07-24 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6004073A (en) * | 1972-09-09 | 1975-03-06 | Basf Ag | Fluorescent benzofuran compounds |
| US4401669A (en) * | 1978-01-27 | 1983-08-30 | Merck & Co., Inc. | 2,3-Dihydro-substituted-5-benzoyl benzofuran-2-carboxylic acids and their use in treating hypertension |
| CA1145758A (en) * | 1979-05-16 | 1983-05-03 | Shell Canada Limited | 2,3-dihydro-2-benzofurancarboxamide derivatives |
| US4237130A (en) * | 1979-06-21 | 1980-12-02 | Merck & Co., Inc. | 2,3-Dihydro-6,7-disubstituted-5-(substituted sulfonyl)benzofuran-2-carboxylic acids |
| DE3317884A1 (de) * | 1983-05-17 | 1984-11-22 | Hoechst Ag, 6230 Frankfurt | 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarbonsaeuren und verfahren zu ihrer herstellung |
| US4544667A (en) * | 1984-02-09 | 1985-10-01 | Merck & Co., Inc. | 2-Sulfamoylbenzo[b]furan derivatives for the treatment of elevated intraocular pressure |
-
1984
- 1984-09-05 JP JP59186971A patent/JPS6163671A/ja active Granted
-
1985
- 1985-08-12 US US06/764,785 patent/US4659709A/en not_active Expired - Lifetime
- 1985-08-13 CA CA000488588A patent/CA1265800A/en not_active Expired - Fee Related
- 1985-08-15 AU AU46215/85A patent/AU592060B2/en not_active Ceased
- 1985-08-16 AT AT85110250T patent/ATE70534T1/de not_active IP Right Cessation
- 1985-08-16 DE DE8585110250T patent/DE3584919D1/de not_active Expired - Fee Related
- 1985-08-16 EP EP85110250A patent/EP0173899B1/en not_active Expired - Lifetime
- 1985-08-19 ZA ZA856277A patent/ZA856277B/xx unknown
- 1985-08-22 NZ NZ213197A patent/NZ213197A/xx unknown
- 1985-08-27 PT PT81033A patent/PT81033B/pt not_active IP Right Cessation
- 1985-09-02 NO NO853441A patent/NO169487C/no unknown
- 1985-09-04 GB GB08521967A patent/GB2164039B/en not_active Expired
- 1985-09-04 DK DK403185A patent/DK165954C/da not_active IP Right Cessation
- 1985-09-04 IE IE218885A patent/IE58911B1/en not_active IP Right Cessation
- 1985-09-04 KR KR1019850006459A patent/KR930002100B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0173899B1 (en) | 1991-12-18 |
| NZ213197A (en) | 1989-01-06 |
| AU4621585A (en) | 1986-03-13 |
| GB2164039B (en) | 1988-05-18 |
| GB2164039A (en) | 1986-03-12 |
| KR930002100B1 (ko) | 1993-03-26 |
| AU592060B2 (en) | 1990-01-04 |
| GB8521967D0 (en) | 1985-10-09 |
| IE852188L (en) | 1986-03-05 |
| EP0173899A3 (en) | 1988-07-20 |
| DK165954B (da) | 1993-02-15 |
| EP0173899A2 (en) | 1986-03-12 |
| DE3584919D1 (de) | 1992-01-30 |
| ATE70534T1 (de) | 1992-01-15 |
| DK403185D0 (da) | 1985-09-04 |
| NO853441L (no) | 1986-03-06 |
| KR860002490A (ko) | 1986-04-26 |
| PT81033A (en) | 1985-09-01 |
| DK165954C (da) | 1993-07-05 |
| JPH0354945B2 (xx) | 1991-08-21 |
| JPS6163671A (ja) | 1986-04-01 |
| US4659709A (en) | 1987-04-21 |
| CA1265800A (en) | 1990-02-13 |
| IE58911B1 (en) | 1993-12-01 |
| NO169487C (no) | 1992-07-01 |
| NO169487B (no) | 1992-03-23 |
| DK403185A (da) | 1986-03-06 |
| PT81033B (pt) | 1987-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2164039B (en) | 2,3-dihydrobenzofuran-5-sulfonamide derivatives | |
| ES296233U (es) | Un sujetador que comprende una serie de porciones de cuerpo sucesivas de diferentes anchuras transversales | |
| AU570142B2 (en) | Purine derivatives | |
| MY117090A (en) | Substituted benzamidines, their preparation and their use as pharmaceutical compounds | |
| GB1503675A (en) | Compositions based on pyrimidine derivatives and their use in the treatment of viral infections | |
| IE822064L (en) | Composition containing human insulin and c-peptide | |
| AU574978B2 (en) | Method for treatment of antidiuresis employing serine derivatives | |
| GB8611946D0 (en) | Pharmaceutical preparations | |
| ES8802372A1 (es) | Procedimiento para preparar un agente que contiene tirosina o un derivado de tirosina como sustancia activa para mejorar la fecundidad de mamiferos. | |
| NZ334949A (en) | Stabilised pharmaceutical composition of quinupristine and dalfopristine with methanesulphonic acid or hydrochloric acid | |
| IE832255L (en) | Treatment of herpes labialis. | |
| FI834045A (fi) | Isokinolinfoerening | |
| ES8801122A1 (es) | Un metodo para preparar tabletas que contienen un compuesto derivado de acido peroxidifosforico no toxico, soluble en agua y farmaceuticamente aceptable. | |
| USD297660S (en) | Shotgun sling | |
| IE820676L (en) | Pharmaceutical preparation | |
| IL75162A0 (en) | Process for the preparation of 4(3h)-quinazolinones | |
| ES8608887A1 (es) | Procedimiento para la obtencion de preparados combinados antihipertensores y antianginicos a base de dihidropiridina y bloquear beta. | |
| Cook | Validation of a growth hormone radioimmunoassay and its application to neuroendocrine studies in the goldfish, Carassius auratus | |
| UA6098A1 (uk) | Спосіб попередження розвитку туберкульозу легень | |
| AU5849886A (en) | Thymidine-kinase (ec2.7.1.21) -deficient mutants of a human monocyte cell line | |
| FR2449452A1 (fr) | Nouveau medicament utile notamment comme diuretique et detoxicant, derive de l'acide galacturonique | |
| JO1378B1 (en) | Innovative galenic forms of sulfides that can be taken orally | |
| FR2244501A1 (en) | 5-Chloro-3-formyl-2-methylindoles - with diuretic analgesic and antiinflammatory activity | |
| JPS54122737A (en) | Remedy for pericementosis | |
| WO1986001716A1 (en) | Use of pyrrothine derivatives |